Marketing Architects Partners with Jounce Media for Greater Transparency in CTV BuyingBusiness Wire • 01/05/26
Jounce Media Designates Yahoo Backstage as the Open Web's Largest MFA-Free Supply SourceBusiness Wire • 09/19/23
JNCE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Jounce Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 03/27/23
Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value RightsGlobeNewsWire • 03/27/23
Jounce Therapeutics Announces Results from Pre-Planned Data Review of INNATE Phase 2 Trial of JTX-8064 and Pimivalimab Demonstrating Deep and Durable Responses in Platinum Resistant Ovarian CancerGlobeNewsWire • 03/16/23
Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra BiosciencesGlobeNewsWire • 03/15/23
Jounce Therapeutics stock bounces after saying only 1.4% of its cash was in an SVB operating accountMarket Watch • 03/13/23
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Jounce Therapeutics, Inc. - JNCEPRNewsWire • 02/28/23
JOUNCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Jounce Therapeutics, Inc. - JNCEBusiness Wire • 02/27/23
JNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Jounce Therapeutics, Inc. Is Fair to ShareholdersBusiness Wire • 02/23/23